mPATH
PrivateLast Round
Seed
Oct 21, 2024
Est. Valuation
$2M
Total Funding Raised
$7.83M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
mPATH operates in Healthcare & Life Sciences and is based in Winston-Salem, North Carolina. Its latest recorded funding round was a Seed round in October 2024.
mPATH is a digital healthcare company that provides a cloud-based platform to help healthcare organizations automate patient outreach and navigation for cancer screenings.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Healthcare Analytics, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
mPATH Comparables
Compare mPATH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Health Catalyst | 75% | |
| CancerIQ | 73% | |
| CipherHealth | 67% |
For institutional investors. Book with your work email.
mPATH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 21, 2024 | ||||
| Grant | Jul 1, 2024 | ||||
| Angel | Mar 5, 2024 | ||||
| Seed | Jun 21, 2022 | ||||
| Accelerator | Jan 25, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
mPATH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Full Circle | Seed |
| TBD Angels | Seed |
| National Cancer Institute | Grant, Angel |
| Graham & Walker | Seed |
| Next Act Fund | Seed |
| Brightside Venture Capital | Seed |
| Next Frontier Capital | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 56% MoM.
- Aug 19, 2025
Partnered with NC DHHS to increase cancer screening.
For institutional investors. Book with your work email.
mPATH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about mPATH's valuation, stock price, and market status.
Is mPATH a public or private company?
mPATH is a private company.
What is the current stock price of mPATH?
mPATH is a private company, so its shares have no public market price. Caplight tracks mPATH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is mPATH worth (valuation)?
mPATH's valuation is estimated at $2.0M based on funding round data.
Can I buy mPATH stock?
mPATH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was mPATH's last funding round?
mPATH's most recent funding round was Seed on October 21, 2024.
Who are the main investors in mPATH?
Key investors in mPATH include Next Frontier Capital, Techstars, Oncology Ventures.
Will mPATH IPO soon?
No public IPO plans have been announced for mPATH.
How can I track mPATH secondary market activity?
Caplight tracks bids, offers, and trades in mPATH's shares on secondary markets.